Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BRODALUMAB Cause Chronic obstructive pulmonary disease? 9 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Chronic obstructive pulmonary disease have been filed in association with BRODALUMAB (Siliq). This represents 0.4% of all adverse event reports for BRODALUMAB.

9
Reports of Chronic obstructive pulmonary disease with BRODALUMAB
0.4%
of all BRODALUMAB reports
0
Deaths
7
Hospitalizations

How Dangerous Is Chronic obstructive pulmonary disease From BRODALUMAB?

Of the 9 reports, 7 (77.8%) required hospitalization.

Is Chronic obstructive pulmonary disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BRODALUMAB. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does BRODALUMAB Cause?

Psoriasis (418) Drug ineffective (177) Arthralgia (175) Fatigue (152) Psoriatic arthropathy (141) Intentional product use issue (136) Headache (126) Therapy interrupted (126) Product dose omission issue (124) Disease recurrence (118)

What Other Drugs Cause Chronic obstructive pulmonary disease?

ALBUTEROL (2,916) TIOTROPIUM (2,895) BUDESONIDE\FORMOTEROL (2,279) FLUTICASONE\SALMETEROL (1,904) ADALIMUMAB (1,712) PREDNISONE (1,237) FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145) MEPOLIZUMAB (1,107) FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967) DUPILUMAB (907)

Which BRODALUMAB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?

BRODALUMAB vs BROLUCIZUMAB BRODALUMAB vs BROLUCIZUMAB-DBLL BRODALUMAB vs BROMAZEPAM BRODALUMAB vs BROMFENAC BRODALUMAB vs BROMHEXINE

Related Pages

BRODALUMAB Full Profile All Chronic obstructive pulmonary disease Reports All Drugs Causing Chronic obstructive pulmonary disease BRODALUMAB Demographics